Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6506|3|1|15-20

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.3, Iss.1, 2007-02, pp. : 15-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beta-Blockers as First Line Treatment of Hypertension: A Proponent's View

By  

Current Hypertension Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 21-28

Bentham Science Publishers

Access to resources Recommend Favorite

Current Place of Beta-Blockers in the Treatment of Hypertension

By  

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 733-741

Bentham Science Publishers

Access to resources Recommend Favorite

Are Calcium Channel Blockers First-Line Drugs for the Treatment of Hypertension and Cardiovascular Disease?

By  

Current Hypertension Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 9-13

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Rationale for the Use of Beta-Blockers in the Treatment of Heart Failure: Special Issue: An Overview of Beta-Blockers and Heart Failure (Guest Editor: Syed M. Jafri)

By Sabbah Hani N.  

Heart Failure Reviews, Vol. 9, Iss. 2, 2004-04 ,pp. : 91-97

Springer Publishing Company

Access to resources Recommend Favorite

Nebivolol vs Amlodipine as First-line Treatment of Essential Arterial Hypertension in the Elderly

By Mazza A.   Gil-Extremera B.   Maldonato A.   Toutouzas T.   Pessina A. C.  

Blood Pressure, Vol. 11, Iss. 3, 2002-05 ,pp. : 182-188

Informa Healthcare

Access to resources Recommend Favorite